Prudential Financial’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-255,733
Closed -$5.47M 2726
2021
Q4
$5.47M Sell
255,733
-31,120
-11% -$613K 0.01% 976
2021
Q3
$5.3M Buy
286,853
+190,452
+198% +$3.83M 0.01% 962
2021
Q2
$2.06M Buy
+96,401
New +$1.96M ﹤0.01% 1460

Other funds holding OCDX

Prudential Financial's OCDX Position: Q1 2022 in Review

Prudential Financial sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 255,733 shares — an estimated $5.47M sold.

Prudential Financial first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $5.47M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Prudential Financial reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Prudential Financial sold 255,733 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $5.47M.
  • Prudential Financial first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
  • Prudential Financial's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.47M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Prudential Financial's 13F filing for Q1 2022, filed 13 May 2022.